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Abstract
Background: MicroRNAs (miRNA) are regulatory genes that target and repress other RNA molecules via sequence-
specific binding. Several biological processes are regulated across many organisms by evolutionarily conserved
miRNAs. Plants and invertebrates employ their miRNA in defense against viruses by targeting and degrading viral
products. Viruses also encode miRNAs and there is evidence to suggest that virus-encoded miRNAs target specific
host genes and pathways that may be beneficial for their infectivity and/or proliferation. However, it is not clear
whether there are general patterns underlying cellular targets of viral miRNAs.
Results: Here we show that for several of the 135 known viral miRNAs in human viruses, the human genes
targeted by the viral miRNA are enriched for specific host pathways whose targeting is likely beneficial to the virus.
Given that viral miRNAs continue to be discovered as technologies evolve, we extended the investigation to 6809
putative miRNAs encoded by 23 human viruses. Our analysis further suggests that human viruses have evolved
their miRNA repertoire to target specific human pathways, such as cell growth, axon guidance, and cell
differentiation. Interestingly, many of the same pathways are also targeted in mice by miRNAs encoded by murine
viruses. Furthermore, Human Cytomegalovirus (CMV) miRNAs that target specific human pathways exhibit increased
conservation across CMV strains.
Conclusions: Overall, our results suggest that viruses may have evolved their miRNA repertoire to target specific
host pathways as a means for their survival.
Introduction
MicroRNAs (miRNA) are ~22nt non-coding regulatory
genes that target other RNA molecules via sequence-speci-
fic hybridization, which results either in translation inhibi-
tion (an imperfect target miRNA sequence match) or in
cleavage and degradation of the targeted RNA (a perfect
target miRNA sequence match) [1]. Initially discovered in
worms, miRNAs are now known to serve numerous criti-
cal regulatory functions in a wide spectrum of species
including viruses [2], plants, and mammals [3]. In mam-
mals, miRNAs play a regulatory role in processes as
diverse as metabolism, immune response, cell death, pro-
liferation, circadian rhythm, and hematopoiesis [4]
Figure 1 depicts all possible miRNA-mediated interac-
tions between a virus and the host. A wide variety of spe-
cies utilize their miRNAs to target and regulate
endogenous pathways (Figure 1a) [5]. Plants, invertebrates
[6], and vertebrates [7] utilize their miRNAs to target
offending virus (Figure 1b). There are known instances of
viruses using their endogenous miRNAs to target their
own genes to evade host immune system’s surveillance and
maintain latency (Figure 1c) [8]. Finally, there are several
known instances of viral miRNAs targeting host genes
(Figure 1d). For instance, Epstein-Barr virus (EBV) encoded
miR-BART5 targets the p53-regulated pro-apoptotic gene
PUMA [9]. More recently, EBV miRNAs were determined
to predominantly target cellular transcripts during latent
infection; 531 sites were identified in 3492 cellular 3’ UTRs
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that contained seed matches to viral miRNAs; of them, 24
were experimentally confirmed [10]. More importantly,
these target genes were enriched for cellular processes that
facilitated the viral infection. This study suggested that the
number of viral miRNA targets in the host may be much
greater than previously assumed and are specific to host
pathways.
Viruses depend upon the molecular machinery of the
cells they infect. They have co-evolved with their host over
millions of years and have had to adapt to the cellular
environment, which in turn is evolving to evade viral
infection. RNA viruses are limited in genomic size due in
part to error prone RNA polymerases. DNA viruses allow
a larger genomic size and a richer gene repertoire to inter-
act with the host and presumably evolve complex mechan-
isms for infectivity and survival; we have therefore
restricted our study to DNA viruses. DNA viruses have
utilized several mechanisms to evade host defenses [11].
Poxviruses and herpes viruses have evolved multiple stra-
tegies to disrupt presentation of viral antigens by MHC
molecules in order to evade control by T lymphocytes
[12]. The adenovirus inhibits MHC-I molecules to evade
immune detection [13]. Viruses have also developed
mechanisms to bolster the host cell to withstand the viral
replication process such as an inhibition of apoptosis [14],
an induction of cellular growth or differentiation [15],
a recruitment of tissue repair processes such as fibrosis
[16], tissue growth [17], and angiogenesis [18].
Evidence presented thus far suggests that viral miRNAs
target host pathways and biological processes that may
potentially benefit viral replication or persistence. If the
suppression of a host gene disables host defense or
enables viral survival or proliferation (e.g., by promoting
cell growth, or inducing repair mechanisms to aid the
survival of the infected cell), then encoding a miRNA
that targets the specific host gene would potentially bene-
fit the virus. While a few previous studies support this
suggestion with specific examples in a limited context
[10,19,20], it is not clear whether there are shared pat-
terns among different viral miRNAs targeting different
hosts. Here we investigate the general patterns of cellular
targeting by viral miRNAs for a comprehensive set of
human and murine viruses.
We found that for several of the 135 known miRNAs
encoded by human viruses, the putative human gene tar-
gets of these viral miRNAs are enriched for specific host
pathways whose targeting is arguably beneficial to the
virus. Many of these pathways, including cancer-related
pathways, melanogenesis, axon guidance, ErbB, GnRH,
Wnt and MAPK signaling pathways are independently
Figure 1 Possible interactions between miRNA and target genes. (a) Endogenous host miRNAs target specific host genes. (b) Host
miRNAs target viral genes. (c) Virus encoded miRNAs target viral genes to mediate immune evasion or maintenance of latency. (d)
Viral miRNAs have been shown to target specific host genes.
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enriched among targets of multiple miRNAs encoded by
multiple viruses. Next, to assess the generality of our find-
ings for known miRNAs, based on previously identified
6809 putative miRNAs encoded by 23 human viruses, we
predicted high-confidence targets of the miRNAs. We
then assessed the enrichment of pathways and Gene
Ontology (GO) functional classes in the target sets. At a
false discovery rate (FDR) of 10%, we found that 75 miR-
NAs, corresponding to 15 viruses, target 43 unique path-
ways. Of these pathways, 20 (6 of which are cancer-related)
were repeatedly targeted by independent miRNAs encoded
by 14 different viruses. A similar analysis of 4 murine
viruses encoding 21 miRNAs also yielded several enriched
pathways and functions which significantly overlapped
with those identified in human. Based on our biological
understanding, the most significant pathways and processes
likely targeted by viral miRNAs present a reasonable choice
from a virus’ vantage point, which include cell growth,
axon guidance, and antigen processing and presentation.
We discuss this in light of current understanding of viral
infection pathways. Moreover, based on genome sequences
of 14 strains of human CMV, we found that the miRNAs
targeting these specific pathways are evolutionarily more
conserved than the other viral miRNAs, suggesting a puri-
fying selection of targeting specific host pathways. Overall,
our results suggest that viruses may have evolved their
miRNA repertoire to target specific host pathways as a
means for their survival and proliferation.
Results
Targets of experimentally validated Human viral miRNAs
are enriched for several pathways and functions
potentially important for viral infectivity and survival
There are 135 experimentally identified miRNAs for the
human viruses included in our study, which are cataloged
on miRBase (http://www.mirbase.org). For each of the 135
known miRNA, we predicted gene targets using the Mir-
anda3.3 tool [21] in the 3’ UTR sequences of 3504 human
protein coding genes, which had unique ENTREZ IDs in
KEGG [22]. We only considered targets with a Miranda
score of at least 140 (which corresponds to a perfect hep-
tamer match in positions 2-8). Beyond this baseline
threshold, we scrambled each of the 3’ UTR sequence and
predicted targets in the scrambled sequences following an
identical procedure and identified a score threshold at
which 1% of the scrambled sequences had a target pre-
dicted. For the putative targets of each miRNA, we then
identified KEGG pathways (http://www.kegg.jp) enriched
in these target gene sets at 1% FDR (see Methods). Table 1
shows the pathways that were enriched in more than one
virus, and in more than 3 independent miRNAs. As we
discuss in detail later, many of these pathways - cancer,
Axon guidance, ErbB, MAPK, and Wnt signaling, etc., are
arguably beneficial targets for the virus.
Pathways targeted by known miRNAs are also enriched
among targets of predicted viral miRNAs
Given that experimentally identified viral miRNAs repre-
sent a potentially very small fraction of all functional viral
miRNAs there is merit to exploring high-confidence pre-
dicted viral miRNAs for evidence of targeting specific host
pathways. We obtained predicted miRNA candidate hair-
pins for double stranded DNA (dsDNA) viruses from Vir-
Mir Database [23]. This includes 6809 miRNA for 23
human dsDNA viruses and 2188 miRNAs for 4 mouse
dsDNA viruses (Table 2). We excluded the papillomaviri-
dae family as it contained fewer than 10 predicted miR-
NAs. For each of the candidate miRNA, we then predicted
gene targets as for the experimentally identified miRNAs
described above. However, we used a miRNA-specific
score threshold at which 5% of the scrambled sequences
had a target predicted; this threshold was always much
more stringent than the baseline threshold of 140.
Next, as above, we tested whether the predicted viral
miRNA targets are enriched for specific KEGG pathways.
To accommodate for potentially high false positives in
predicted miRNAs, we employed additional criteria for the
selection of enriched pathways. After assessing the overlap
between the predicted miRNA targets and the genes in the
pathway using a hypergeometric test, we further adjusted
Table 1 Targets of known human viral miRNA are enriched for KEGG Pathways.
KEGG Pathway Name Total (135) HSV1 (25) HSV2 (24) EBV (44) CMV (17) KSHV (25)
Cancer 10(27) 2(3) 2(4) 2 (3) 1(6) 3(11)
ErbB signaling pathway 9 3 2 4 0 0
Axon guidance 7 3 1 1 0 2
Melanogenesis 6 2 2 0 1 1
MAPK signaling pathway 5 0 1 0 1 3
GnRH signaling pathway 4 0 0 0 1 3
Wnt signaling pathway 4 1 0 1 1 1
Individual viral miRNAs target human genes that are enriched for KEGG pathways, and multiple viruses target the same pathways even across virus families. We
list the pathways that were represented multiple times with a FDR of 1%. The name of the virus and number of known miRNA used for analysis is supplied as
the header; the values indicate the number of miRNA that are enriched for the pathway listed. Cancer pathways were aggregated into one category and the
value indicates the number of miRNA that are enriched for a cancer-related pathway and in parenthesis is the total number of cancer pathways enriched.
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p-values based on a randomized sampling approach in a
pathway-specific fashion, controlling for the lengths of the
target genes 3’ UTR. Finally, we corrected the adjusted
p-values for multiple testing (see Methods). Based on FDR
threshold of 10%, a total of 43 unique pathways were
enriched for 75 miRNAs in 14 human viruses. Table 3
shows KEGG pathways that were enriched among the tar-
gets of miRNAs in more than two viruses.
We assessed whether the distribution of the number of
miRNAs targeting a pathway is skewed relative to expec-
tation. Given the bipartite graph composed of miRNAs
(whose targets are enriched for specific pathways) and
the corresponding enriched pathways, we randomized
the bipartite graph while preserving the degree of each
miRNA, in order to estimate the expected degree distri-
bution of pathways. The degree distribution for the real
data is skewed towards higher values (Kolmogorov Smir-
nov (KS) test p-value = 0.029). The antigen processing
and presentation pathway was specifically enriched
among the targets of twelve miRNA. Based on 1000 ran-
domizations of the bipartite graph; the probability of this
occurrence is less than 0.0001. Three pathways were
enriched in targets of 7 or more miRNAs (p-value =
0.016 based on 1000 randomizations).
Human viral miRNA targets are enriched for specific GO
functions
While the pathway-enrichment analysis can reveal very
specific biology, it is also limited by our knowledge of
pathways. We therefore extended our pathway-enrichment
procedure above to search for enriched GO biological pro-
cesses. As before, we applied a term-specific adjustment of
p-value, applied multiple testing corrections, and used a
FDR threshold of 10% to select for enriched GO terms.
Table 3 shows GO terms that were enriched among the
targets of miRNAs in more than one virus. An interesting
set of terms not revealed by KEGG pathway analysis
became apparent (discussed later). As above, we analyzed
Table 2 Viral miRNA selection.
Virus miRNA Virus miRNA Virus miRNA
Human adenovirus A 20 Human adenovirus Type 35 54 HSV6B 107
Human adenovirus C 104 Human adenovirus Type 5 114 HSV7 54
Human adenovirus D 136 Human adenovirus Type 7 78 HHV8(KSHV) 392
Human adenovirus E 132 HSV1 939 Orf virus 953
Human adenovirus F 58 HSV2 840 Vaccinia virus 38
Human adenovirus Type 11 52 HSV3 (dumas) 111 Muridherpes 1 1158
Human adenovirus Type 1 122 HHV4(EBV) 741 Muridherpes 2 894
Human adenovirus Type 17 136 HHV5(CMV) 1444 Muridherpes 4 98
Human adenovirus Type 2 124 HSV6 98 Murine adenovirus A 38
Species specific viruses containing 10 or more miRNA were selected from VirMir DB. The virus name and number of miRNAa re listed.
Table 3 Human miRNA targets are enriched for KEGG Pathways and GO terms, and multiple viruses target the same
pathways even across virus families.
KEGG Pathway adeno/herpes/pox Gene Ontology adeno/herpes/orf
#miRNA # virus #miRNA # virus
Biosynthesis of steroids 2/1/0 2/1/0 Cytoplasmic microtubule 0/9/0 0/3/0
Glycerolipid metabolism 0/3/1 0/3/1 Microtubule binding 0/9/0 0/2/0
ErbB signaling pathway 7/0/0 4/0/0 Kinase binding 0/8/0 0/2/0
Regulation of autophagy 2/1/0 2/1/0 Cytoplasmic vesicle membrane 4/4/0 4/3/0
Hedgehog signaling pathway 0/3/0 0/2/0 Inner ear morphogenesis 0/8/0 0/2/0
Axon guidance 3/5/0 2/3/0 Multicellular organismal development 0/7/0 0/5/0
Antigen processing and presentation 3/6/3 2/4/1 Transferrin transport 4/3/0 4/2/0
Long-term potentiation 0/4/0 0/2/0 Protein autophosphorylation 5/2/0 5/1/0
GnRH signaling pathway 2/2/0 2/2/0 Protein serine/threonine kinase activity 0/5/1 0/5/1
Cancer 3/17/7 2/6/1 Extracell-glutamate-gated ion channel activity 5/1/0 4/1/0
Voltage-gated ion channel activity 1/5/0 1/3/0
Synaptic transmission 1/5/0 1/4/0
Histone methylation 0/4/2 0/3/1
Canonical Wnt Receptor signaling pathway 0/4/2 0/3/1
We list the pathways that were represented multiple times with an FDR of 10%. The numbers separated by a slash correspond to adeno, herpes and orf families
of viruses.
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the degree distribution associated with GO terms in the
bipartite graph composed of enriched GO terms and miR-
NAs. As before, the GO terms were multiply targeted
more frequently than expected (KS test p-value = 0.007).
Cytoplasmic microtubule and microtubule bindings were
enriched for 9 miRNA.
It is possible that a pathway/GO term is enriched
among targets of multiple miRNAs simply due to a high
similarity of the miRNA sequences, and could not be
interpreted as independent evidence. To rule out this
possibility we analyzed the pair-wise overlap in target
sites for miRNAa enriched the same functional term (see
Methods). For each miRNA pair, we calculated the over-
lap as the fraction of all target sites (for the miRNA with
fewer hits) that overlapped with the target sites of the
other miRNA. We found that in almost all cases (99%),
the overlap was less than 0.05. Thus, the miRNA
sequence similarity does not explain the common path-
way enrichment. Taken together, our results suggest that
several pathways and GO terms are targeted indepen-
dently by multiple miRNAs.
Human and mouse viruses target similar processes
Next, we investigated whether our finding in human - viral
miRNAs tend to target critical host pathways - also holds
in other species, and whether similar pathways and func-
tions are targeted in evolutionarily distant species. We used
herpes and adeno virus specific for mice and performed an
identical KEGG pathway and GO term enrichment ana-
lyses as was used for human miRNAs. By necessity, the
enrichment was restricted to genes with mapped unambig-
uous human-mouse orthologs; this reduced the size of the
KEGG gene list for enrichment purposes from 3504 genes
to 1381 genes, and the pathway list from 201 down to 189.
None of the miRNA target sets from the mouse adeno
family were enriched for a functional term at the 10% FDR
threshold. For the herpes family, we found substantial over-
lap among the processes and pathways targeted by mouse
and human viruses in their respective hosts, namely the
ErbB signaling pathway, axon guidance, neuron develop-
ment, regulation of immune response, and Insulin receptor
regulation. Table 4 shows the pathways that were multiply
targeted in at least one species. There was only one experi-
mentally verified mouse miRNA included in our study and
it was enriched for cell communication pathway, neuron
differentiation, and cellular response to retinoic acid
processes.
Viral miRNAs targeting specific host processes are
potentially evolving under purifying selection
Many of the miRNAs encoded by EBV have been sug-
gested to target host genes and were shown to be evolu-
tionarily conserved [24]. Next, we investigated if the viral
miRNAs that target specific host processes are evolving
under differential pressure relative to other miRNAs. We
obtained and aligned 14 CMV strain sequences [25] to
reference the VirMir strain using ClustalW [26]. Given
the multiple alignment we calculated the average conser-
vation score for each miRNA, defined as a fraction of the
consensus base at each position, averaged across the
length of the miRNA. Those that putatively target speci-
fic host processes are significantly more conserved than
the miRNAs that do not target a specific host pathway
(Wilcoxon p-val 0.047), suggesting that they are evolving
under purifying selection. This analysis could not be
extended to other strains due to paucity of strains and
inter-strain variability.
Discussion
Targeting specific host processes by viral miRNA are
prevalent mechanisms of viral infectivity
Given that DNA viruses encode for miRNAs that can be
effectively processed by the host machinery [27], it stands
to reason that targeting of specific host genes by viral
RNA may be effective ammunition against host defense. A
single miRNA may target hundreds of genes for regula-
tion, and identifying the true targets of miRNAs remains a
challenge. This study was designed to investigate the
Table 4 Mouse and human virus target similar KEGG
pathways and GO terms.
KEGG Pathway Mouse/
Human
Synthesis and degradation of ketone bodies 2/1
C21-steroid hormone metabolism 1/2






Multicellular organismal development 3/5
Neuron development 3/4
Regulation of immune response 4/3
Peptidyl-tyrosine phosphorylation 3/3




Positive regulation of muscle cell differentiation 3/2
Negative regulation of insulin receptor signaling
pathway
5/4
Positive regulation of phosphatidylinositol 3-kinsase
activity
3/4
Insulin receptor signaling pathway 3/4
Mouse and human viruses target genes sharing similar cellular signaling
pathways and GO terms despite large divergence in 3’UTRs. KEGG pathways
and GO terms which were enriched for multiple miRNA and multiple virus
strains in one species are listed.
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possibility that virally-encoded miRNAs target host genes
in pathways central to the persistence and/or replication
strategies of many viruses. We first tested for enriched
pathways among putative targets of known human viral
miRNAs from miRbase. Recent next-generation sequen-
cing efforts have revealed new viral miRNAs, and this
trend is likely to continue as more cell types and tissues
are analyzed [28] (and unpublished data by Trgovcich).
Therefore, given that a vast majority of viral miRNAs
remain to be identified, we used a dataset of predicted
viral miRNA to test the generality of our findings for
known miRNAs. Based on a stringent analysis, our results
support the general hypothesis.
A few aspects of our finding are worth highlighting.
First, published experimental data suggests that many of
the pathways and processes putatively targeted by viral
miRNAs make excellent targets to aid viral infectivity and
survival. Second, we found that many KEGG pathways
and GO biological processes are targeted by multiple miR-
NAs from multiple viruses, even across viral families. For
instance, miRNAs targeting antigen processing and pre-
sentation and gonadotropin receptor hormone signaling
are enriched in both adeno and herpes virus families.
While it is known that herpes reside in neuronal cells dur-
ing latency [29], axon guidance pathways are also enriched
by both viral families, which is surprising because adeno
viruses are normally associated with lung or gastrointest-
inal infections, and not neuronal cells [30]. The other
commonality between both virus families was the cancer-
related pathways, which we categorized as one group.
Third, we also found many of these enriched targets in
human to be the same when we repeated our analysis
independently in mouse viruses. For example, cancer and
the ErbB signaling pathway, insulin receptor regulation,
and axon guidance pathways are preserved between
mouse and human viral targets. We discuss a selection of
enriched pathway in more detail below. Finally, we found
evidence to suggest that the miRNAs targeting specific
host processes are evolving at a relatively slower rate than
other miRNAs. This is consistent with previous findings in
EBV that showed viral miRNAs are likely to target host
genes that are evolutionarily conserved [24]. We note that
the evolutionarily conserved miRNAs in our analysis are
not biased towards known miRNAs.
A few previous studies report similar findings, although
in a limited context. A previous analysis showed enrich-
ment for KEGG pathways associated with cell signaling
and adhesion/junction pathways using the putative targets
of 85 known miRNAs in 5 human herpes virus as an
aggregate (not virus-specific or miRNA-specific) [19].
Another study of known KSHV miRNAs and targets pre-
dicted by differential expression analysis found the targets
to be involved in proliferation, immune modulation,
angiogenesis, and apoptosis [31]. Finally experimentally
identified targets for EBV were found to be enriched for
targets involved in innate immunity, cell survival, and cell
proliferation [10]. Here we verified these previous finding
and extended the analysis to individual viruses and miR-
NAs as well as broadened the virus families to include the
adenoviruses and poxviruses. Furthermore, by including
human and mouse viruses, our analyses support evolution-
ary prevalence of viral miRNAs targeting host pathways
and processes for their survival and proliferation. Finally,
we present evidence for possible purifying selection, acting
on certain miRNAs targeting specific host processes.
Caveats
While miRNA prediction is challenging in general, it is
especially difficult to predict viral miRNAs, because most
miRNA prediction approaches have been developed for
eukaryotes and exploit evolutionary conservation [32],
and are thus not applicable to viruses. Current miRNA
prediction in viruses essentially relies on identifying hair-
pin like structures with certain additional properties [23].
We started with the putative miRNAs for dsDNA viruses
compiled in the VirMir [23]. Undoubtedly, many of these
predicted miRNAs will be false positives. However, the
complete set of viral miRNAs is far from known. For
instance, since 2007 in VirMir database, the number of
known miRNAs for viruses studied here has grown
greater than three-fold, and will grow as technologies
improve and as additional cell types and tissues infected
by viruses are analyzed. Using the group of all potential
viral miRNAs based on predicted hairpin precursor
structures therefore allowed us to begin with most com-
prehensive set of putative target genes for statistical ana-
lysis. Predicting miRNA targets presents yet another
complication, especially for viruses, for similar reasons,
and is fraught with false positives. A 24% false discovery
rate has been calculated for MiRanda[33] similar to other
target prediction algorithms. To minimize false positives
from the putative miRNAs collected from VirMir, we
restricted the target scores to a value of 140 or higher
which correspond to exact seed matching criteria as well
as a further threshold based on target score distribution
for scrambled 3’UTR sequences. We adopted several
additional checks to minimize false positives at the stage
of functional enrichment assessment. First, we performed
a strict pathway-specific adjustment of p-values account-
ing for 3’ UTR lengths of genes in the pathway (a novel
aspect of this work) and applied multiple testing correc-
tions. Second, we used multiple virus families. Third, we
relied on both KEGG and GO to better interpret our
findings, and we used two distant species to corroborate
our findings. Lastly, we compared the evolutionary con-
servation of miRNAs targeting specific host pathways to
the other miRNAs based on 14 distinct strains of CMV
and determined that they are conserved much more than
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expected, suggesting a selective pressure to maintain the
targeting specificity. Although there are likely to be many
false positives at the level of individual target genes, due
to the reasons listed above, it is encouraging that they
still reveal biologically meaningful patterns of functional
enrichments.
Pathways targeted by viral miRNAs
We found that miRNAs in many viruses targeted similar
pathways even across distant host species. We compared
the pathway enrichment for known viral miRNA in
miRBase with that for predicted miRNAs in VirMir. For
brevity, we discuss in detail the biological significance of
three most significant pathways.
Cancer
It is encouraging that cancer, as a theme, is repeatedly
revealed by our analysis. It is becoming increasingly clear
that miRNAs may have a causal role in initiation and
progression of cancer [34]. A few viruses included in this
study are known to be associated with human cancer
such as EBV in Burkett’s lymphoma and nasopharyngeal
carcinoma, and KSHV in Kaposi’s sarcoma and some B
cell lymphomas, but there is no direct evidence yet that
viral miRNAs play a causal role in the development of
cancer. Oncogenic pathways that viruses are known to
interfere with include (1) cell growth, (2) proliferation,
(3) evasion of apoptosis, (4) genetic instability, and (5)
angiogenesis. The enriched KEGG pathways by both
mice and humans include one pathway and three GO
terms associated with features deregulated in cancer, in
addition to the cancer pathway. Regulation of the MAPK
signaling pathway is an essential co-factor for re-activa-
tion of KSHV [35]. A closely related PI3K pathway, tar-
geted by herpes viruses, is critical to cell survival and
growth [36], and is frequently activated in cancer path-
ways [37]. Both pathways have the potential to inhibit
KSHV infections [38]. The PI3K pathway is a particular
favorite for DNA viruses enabling infected cells to with-
stand viral induced stress [39]. DNA viruses can affect
ErbB signaling pathway, which can initiate the MAPK
pathway resulting in growth or differentiation [40].
Enrichment for these pathways suggests that viral miR-
NAs may play a role in the oncogenesis.
Hedgehog and insulin regulation
The Hh genes regulate tissue patterning and are
expressed in the beta cells of the pancreas and was impli-
cated in insulin production [41]. Hepatitis infection
induces Hh pathways and is associated with fibrogenic
repair, and vascular remodeling [42]. The viral need for
tissue repair could be categorized as stress management
so that the infected cell can withstand the stresses of viral
replication programs; however, it is not clear why a virus
would need to regulate insulin. Insulin is a metabolic
molecule that causes tissue to take up glucose from the
blood and to stop using fat as an energy source; it is pos-
sibly used as a metabolic regulator. One can speculate
that viral hijacking of the key energy regulator may
induce the infected cell to devote their energy production
to the virus’ needs. Enrichment of the GO term for nega-
tive regulation of insulin receptor signaling and insulin
receptor signaling pathway would indicate that insulin
regulation is indeed the targeted pathway.
Neuronal growth
HSV is commonly latent in nerves, and during an infec-
tion the virus travels along the nerves to the connected
tissue and forms lytic lesions. Nerve growth factors are
necessary survival factors for HSV in latency [43]. Addi-
tionally, it has been shown that HSV utilizes nerve growth
cones and varicosities of axons for transport [44] indicat-
ing a role in nerve growth pathways. What is surprising is
that three miRNA from two different adeno viruses were
enriched for axon guidance pathway in humans. Because
adeno viruses do not usually target neurons, it is likely
that this is a false positive. Nevertheless, viral miRNA tar-
gets are enriched for axon guidance and GO term neuron
development and support the targeting of this important
latency pathway for the herpes virus.
Materials and methods
MiRNA target prediction
Given a miRNA sequence from VirMir [23], and the 3’
UTR of human (or mouse) genes, we used Miranda3.3 to
predict the miRNA targets [45]. As a baseline threshold,
we only considered Miranda hits scoring 140 or higher,
which corresponds to a perfect heptamer match in posi-
tions 2-8 and should be considered stringent [45]. As a
further control, we randomly scrambled each 3’ UTR
sequence and repeated the target prediction on the ran-
domized sequences. Using the distribution of scores on
the randomized sequences, we determined a score cutoff
corresponding to top 1% (for analysis of known miRNA)
or 5% (for analysis of predicted miRNAs) scores. This
threshold was determined separately for each miRNA
and was always much more stringent that the baseline
score threshold of 140.
Functional enrichment
We compared each gene target set with an annotated
functional gene sets corresponding to KEGG pathways
and GO biological processes; gene sets with fewer than
10 members were excluded. For each miRNA we assessed
overlap between the miRNA target set and each func-
tional gene set using a hypergeometric test, which esti-
mates the probability (p-value) of observing an overlap of
certain size of greater between two gene sets by random
chance. We noted that if the genes in functional gene set
have longer 3’ UTRs, then those pathways are more likely
to be deemed as enriched simply by chance. To control
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for 3’ UTR length bias, we divided the range of 3’ UTR
lengths into 20 equal-sized bins. For a miRNA, for each
target of that miRNA, we randomly selected a gene in the
same 20 percentile bin, thus generating a length matched
random set of target genes for each miRNA; we gener-
ated 10 such random sets corresponding to each actual
target set. For each randomize target set, we calculated
the hypergeometric p-value for the overlap with each
functional gene set. Thus, for a functional gene set
(KEGG or GO), we generated a NULL distribution of
hypergeometric p-values containing 68,090 p-values cor-
responding to 10 randomized sets corresponding to 6809
miRNAs. Given an actual miRNA target set S and func-
tional gene set F, and given the hypergeometric p-value
P(S, F), we estimated an adjusted p-value PAdj(S, F) as the
rank of P in the 68,090 p-values corresponding to F.
Finally, given adjusted p-values for all miRNA target sets
for all viruses against all functional gene sets, we cor-
rected the adjusted p-values for multiple testing using
the Benjamini-Hochberg procedure for FDR estimation
[46].
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